Found 9 matching trials
Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
PHASE2The primary purpose of this study is to evaluate the efficacy and safety of...
Location
Shanghai Jiao Tong University Chest Hospital
Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer
PHASE2This is a single-arm, exploratory trial to evaluate the efficacy and safety...
Location
Shandong Cancer Hospital and Institute
Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
N/AThis observational study aims to evaluate the real-world effectiveness and ...
Location
Peking University Shenzhen Hospital
Cerebrospinal Fluid Immune Microenvironment Mechanism in Anaplastic Lymphoma Kinase Positive Lung Cancer Patients
PHASE2This is an an interventional study to explore the mechanism of cerebrospina...
Location
Multiple Locations
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC
PHASE2The aim of this trial is to evaluate the safety of WX-0593 combined with co...
Location
Shandong Cancer Hospital and Institute
Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
PHASE3The primary purpose of this study is to evaluate the efficacy and safety of...
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer
PHASE2The purpose of the study is to evaluate safety and efficacy of WX-0593 oral...
Location
The First Affiliated Hospital of Anhui Medical University
A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients
PHASE1The purpose of the study is to evaluate safety, pharmacokinetics and effica...
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers
PHASE1This is an open-label, single dose, mass balance and biotransformation stud...
Location
The First Affiliated Hospital of Soochow University